Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Interim Statements of Cash Flows

v3.19.3
Condensed Interim Statements of Cash Flows - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating activities:        
Net loss for the period $ (14,472,866) $ (5,885,415) $ (42,755,746) $ (6,694,114)
Items not involving cash:        
Amortization 7,291 5,372 13,466 17,114
Stock based compensation 740,051 356,348 991,408 723,405
Other share compensation       66,234
Warrant liability-fair value adjustment (6,609,952) (2,210,537) 3,866,673 (5,853,111)
Warrant liability-foreign exchange adjustment 142,682 (421,301) 36,625 (935,656)
Changes in non-cash working capital items:        
Amounts receivable, prepaid expenses and deposits 1,294,599 (10,120) (283,330) (1,818,430)
Accounts payable and accrued liabilities 5,736,133 1,274,644 5,783,889 1,970,483
Cash used in operating activities (13,162,062) (6,891,009) (32,347,015) (12,524,075)
Financing activities:        
Net proceeds from issuance of common shares and warrants (2,997) 8,828,240 31,374,911 8,857,740
Cash provided by financing activities (2,997) 8,828,240 31,374,911 8,857,740
Investing Activities:        
Cost of Patents (125,198) (40,491) (178,956) (97,039)
Cash used in investing activities (125,198) (40,491) (178,956) (97,039)
Increase (Decrease) in cash and cash equivalents (13,290,257) 1,896,740 (1,151,060) (3,763,374)
Cash and cash equivalents, beginning of the period 23,610,440 20,470,379 11,471,243 26,130,493
Cash and cash equivalents, end of the period 10,320,183 22,367,119 10,320,183 22,367,119
Cash and cash equivalents comprise:        
Cash 1,392,741 134,243 1,392,741 134,243
Cash Equivalents 8,927,442 22,232,876 8,927,442 22,232,876
Cash and cash equivalents, end of the period $ 10,320,183 $ 22,367,119 $ 10,320,183 $ 22,367,119